Video Experimental Relacionado
Updated: Sep 9, 2025
06:39
Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
Published on: October 27, 2023
1.1K
Fotobiomodulación preventiva y autoaplicada en el tratamiento de la mucositis oral: un estudio de caso de alto riesgo
Joseph Ryan1, Lee Na Chong2,3,4, Robert Jared Dunn4
1School of Rural Medicine, Charles Sturt University, Orange, NSW, Australia.
Case reports in oncology
|August 29, 2025
Resumen
La fotobiomodulación preventiva (PBM) utilizando láseres de 904 nm y 600 nm redujo efectivamente la gravedad de la mucositis oral en un paciente con cáncer de alto riesgo. Este enfoque es prometedor para mejorar la calidad de vida durante el tratamiento antineoplásico.
Área de la Ciencia:
- En el campo de la oncología
- Ingeniería biomédica
- Terapia con láser
Sus antecedentes:
- La mucositis oral (MO) es un efecto secundario debilitante de los tratamientos contra el cáncer como la quimiorradiación.
- La fotobiomodulación (PBM) utilizando luz roja e infrarroja cercana es una intervención prometedora para el OM.
- El calendario y los métodos óptimos de administración del PBM requieren más investigación.
Videos de Conceptos Relacionados
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
684
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
684
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
595
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
595